(Q39733069)

14 September 2017

1 reference

title

Neuroendocrine predictors of electroconvulsive therapy outcome. Dexamethasone suppression test and prolactin (English)

1 reference

dexamethasone suppression test

14 September 2017

0 references

1 reference

Fink M

1

1 reference

PubMed ID

3518572

14 September 2017

language of work or name

English

0 references

publication date

1 January 1986

1 reference

Annals of the New York Academy of Sciences

14 September 2017

1 reference

14 September 2017

462

1 reference

14 September 2017

30-36

1 reference

A theory of convulsive therapy in endogenous depression: Significance of hypothalamic functions

14 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1986.TB51236.X

Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1986.TB51236.X

Prolactin changes during electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1986.TB51236.X

Prolactin response to electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1986.TB51236.X

Immediate increases in plasma prolactin and neurophysin but not other hormones after electroconvulsive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1986.TB51236.X

10.1111/J.1749-6632.1986.TB51236.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference

PubMed ID

3518572